Market Access Landscape Assessment
Market access strategy needs to be developed by focusing on the end customer be it payer/clinician/patient. Evidinno’s comprehensive market access landscape assessment involves identifying the unmet needs, pricing, HTA assessments, funding, and market access of products in the relevant therapeutic area using industry standard primary and secondary research methodologies for evidence selection and synthesis.
Evidinno’s extensive experience in conducting landscape assessments allows the analysis and understanding of the historical and current market access landscape for building a robust market access strategy at an early stage of product lifecycle.
External Reference Price Maps
External Reference Price Maps consist of officially published prices of a drug across countries that use external reference prices to officially or unofficially benchmark prices for the main goal of controlling drug prices. These price maps can be used for either short-term analysis or long-term price-setting strategy.
Evidinno’s team of experts can support development of robust price maps using reference pricing data sourced directly from national health agencies where available.
Health Technology Assessment Analysis
The demand of Health Technology Assessment is growing in reimbursement decision making, thereby increasing the importance of HTA consulting. HTAs are likely to play an increased role in the adoption and reimbursement of new products around the globe. Evidinno has the capability to support a range of reimbursement strategy related activities including:
- HTA Analysis of Competitor Submissions: To understand the dynamics of decisions a HTA body makes on direct competitor drugs and to identify key drivers of HTA agency decisions and recommendations for achieving market access in a timely manner.
- Reimbursement and Access Roadmap: Understanding the reimbursement and access pathway is critical for planning evidence generation and preparing submission documents, especially in challenging markets such as Middle East, South East Asia, and African regions.
Value Dossiers (AMCP and Global)
Value dossiers develop the value story of an asset of interest, by providing support to the clinical, economic and humanistic value of an intervention, as well as describing the global burden of disease for the related therapeutic area. Such documents are key components of bringing new products to market, and Evidinno’s team of expert epidemiologists and health economists help to provide groundwork and specific evidence in support of the drug, tailored to frame the value messaging.
411 – 63 West 6th Avenue Vancouver, BC, Canada V5Y 1K2
Evidinno provides high quality health outcome and research consulting services for clients worldwide.